Evaluation of treatment regimens and long-term clinical outcomes in patients with isoniazid-resistant pulmonary tuberculosis: a 5-year follow-up

BACKGROUND/AIM: Considering its early bactericidal activity, isoniazid (H) is an important first-line agent in tuberculosis (TB) treatment. The aim of this study was to evaluate the treatment regimens and results of H-resistant pulmonary TB patients. MATERIALS AND METHODS: We retrospectively evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: ASLAN, Ayşe Feyza, ORTAKÖYLÜ, Mediha Gönenç, BAĞCI, Belma Akbaba, TOPRAK, Sezer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific and Technological Research Council of Turkey (TUBITAK) 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388119/
https://www.ncbi.nlm.nih.gov/pubmed/37476899
http://dx.doi.org/10.55730/1300-0144.5639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388119/
https://www.ncbi.nlm.nih.gov/pubmed/37476899
http://dx.doi.org/10.55730/1300-0144.5639

Ejemplares similares